Biogen reanalyzes studies, presses ahead on Alzheimer’s drug

Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer’s disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia.

The announcement was a surprise because the drug company earlier this year stopped two studies of the drug when partial results suggested it was not likely to be successful. The company now says a new analysis of more results suggest that the drug helped reduce a decline of thinking skills at the highest dose.

The drug, called aducanumab, aims to help the body clear harmful plaques from the brain. Cambridge, Massachusetts-based Biogen is developing it with a Japanese company, Eisai Co. Ltd.

More than 5 million people in the United States and millions more worldwide have Alzheimer’s. Current drugs only temporarily ease symptoms and do not slow the loss of memory and thinking skills. Dozens of efforts to develop a drug to slow or reverse the course of the disease have failed.

The two studies tested aducanumab, given as monthly infusions, in more than 3,000 patients with mild cognitive impairment or early dementia due to Alzheimer’s. The company said Tuesday that in one study, those given a high dose showed 23% less decline on one measure of thinking skills and smaller declines on other measures.

However, no details were given on how much that decline meant in absolute terms. For example, the company didn’t say how much difference it made in practical matters, like whether patients were able to dress or feed themselves or live independently longer, just that these skills overall declined less for those on the high dose of the drug.

“It’s a tricky question” whether the results are truly meaningful for patients until more details are known, said Dr. Ronald Petersen, a Mayo Clinic dementia specialist who has consulted for Biogen on the studies.

But filing for federal Food and Drug Administration approval “gives some hopes for patients and families that there may be disease-modifying therapies out there,” he said.

The company said more details would be given at a conference in December, including on safety. The company said the most common side effects were inflammation in the brain, most of which did not cause symptoms or lasting problems, and headaches. The brain inflammation has been seen in other studies of Alzheimer’s medicines that target the brain plaques.

“We’re really encouraged by the information that they’ve provided today,” the largest benefit so far for any experimental medicine, said Rebecca Edelmayer, a scientist at the Alzheimer’s Association, which had no role in the studies.

Biogen said it would offer aducanumab now to patients enrolled in these and earlier studies of it.

Biogen shares were up more than 26% to $281.87 Tuesday, but some on Wall Street remained skeptical.

Mizuho Securities USA analyst Salim Syed said he wants to know more about the FDA’s involvement in Biogen’s decision. He also said in a research note that it’s still just a hypothesis that removing beta amyloid plaques can benefit Alzheimer’s patients.

The company’s announcement “does not guarantee approval and questions remain,” he said.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Health Minister Tyler Shandro and Dr. Deena Hinshaw, the chief medical officer of health, receive flu shot. Photo via Government of Alberta
COVID cases climb in central zone, Red Deer

The total number of active COVID-19 cases in the province reached 3,138… Continue reading

Many rural municipalities were concerned about a proposed reduction to their industrial revenues, but Alberta’s municipal affairs minister has come up with an alternative solution. (Photo contributed)
Energy industry support won’t injure municipalities

Creating new wells or pipelines would result in a three year ‘tax holiday’

Conservative Leader Erin O’Toole and Premier Jason Kenney participated in a livestream on Oct. 17, 2020. (File photo by THE CANADIAN PRESS)
UCP members pass resolution at AGM calling for privately funded health care option

EDMONTON — Members of Alberta’s governing United Conservative Party have narrowly endorsed… Continue reading

“We weren’t sure what to expect with just doing the 50/50. We have been positively surprised with sales so far,” says Craig Fleming, co-chair of the Red Deer Kinsmen Club’s raffle. (Photo by SUSAN ZIELINSKI/Advocate staff)
Non-profits put their money on 50/50 draws

COVID impacts fundraising events

Student taking a math test. (Pixabay photo)
David Marsden: Students need more testing, not less

Testing has been central to Alberta’s response to the COVID-19 pandemic. It’s… Continue reading

Gillian Robertson celebrates her win over Sarah Frota during UFC 240, in Edmonton, Saturday, July 27, 2019. Robertson used her superior grappling skills to dominate Brazil's Poliano Botelho en route to a unanimous decision win Saturday night on a UFC Fight Night card. THE CANADIAN PRESS/Jason Franson
Canadian Gillian (The Savage) Robertson dominates in UFC decision win in Abu Dhabi

Canadian Gillian (The Savage) Robertson dominates in UFC decision win in Abu Dhabi

Forge FC head coach Bobby Smyrniotis, right, hugs captain Kyle Bekker following their victory in the Canadian Premier League soccer final against Cavalry FC in Calgary, Saturday, Nov. 2, 2019. A month after winning the Island Games in Charlottetown, Hamilton-based Forge FC is back on the move. THE CANADIAN PRESS/Jeff McIntosh
CPL champion Forge FC off to El Salvador for CONCACAF League preliminary-round match

CPL champion Forge FC off to El Salvador for CONCACAF League preliminary-round match

Course workers prepare the landing area at the ski jump venue in Whistler Olympic Park in Whistler, B.C. Friday, Feb. 5, 2010. THE CANADIAN PRESS/Jonathan Hayward
Next generation of Canadian ski talent sets sights on Whistler, B.C., in 2023

Next generation of Canadian ski talent sets sights on Whistler, B.C., in 2023

Mighty Heart is held by groom Siobhan Brown in his stall at trainer Josie Carroll's stable at Woodbine Racetrack, in Toronto, Thursday, Oct. 15, 2020. The one eyed horse, will run in the $400,000 Breeders' Stakes on October 24, attempting to become Canada's first horse to win the Triple Crown since Wando in 2003. THE CANADIAN PRESS/Chris Young
Rain could present big challenge in Mighty Heart’s quest to capture Triple Crown

Rain could present big challenge in Mighty Heart’s quest to capture Triple Crown

Veteran sniper Evgenii Dadonov excited to join Senators: ‘It’s a perfect fit’

Veteran sniper Evgenii Dadonov excited to join Senators: ‘It’s a perfect fit’

Tampa Bay Buccaneers running back Ronald Jones II (27) gets pushed out of bund by Green Bay Packers free safety Darnell Savage (26) during the second half of an NFL football game Sunday, Oct. 18, 2020, in Tampa, Fla. (AP Photo/Mark LoMoglio)
Packers seek to bounce back after embarrassing defeat

Packers seek to bounce back after embarrassing defeat

World junior hockey championship opens on Christmas Day for first time since 2005

World junior hockey championship opens on Christmas Day for first time since 2005

Most Read